5th gen glp-1 Transforming obesity: The advancement of multi-receptor drugs: Cell The new generation of weight

Diabetes (2018) 67

Persistence tends to improve when patients receive structured support

Transitioning Medicare coverage of GLP-1s for obesity from the mandatory Medicare GLP-1 Bridge to the voluntary BALANCE model sets up the possibility that beneficiaries with coverage under the short-term program may need to switch Part D plans during the 2027 open enrollment period, with potential cost and coverage implications for other medications they use.

Purification and identification of novel antioxidant peptides from watermelon seed protein hydrolysates and their cytoprotective effects on H 2 O 2 -induced oxidative stress